Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{191496,
        author = {Rakesh Kumar Pandey and Dr. Sanjay Kumar Kushwaha},
        title = {Designing of a Polyherbal Formulation for Metabolic Disorders: A Comprehensive Review},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {7183-7190},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=191496},
        abstract = {Metabolic disorders (MetS), characterized by a cluster of conditions including central obesity, insulin resistance, dyslipidemia, and hypertension, represent a major global public health challenge. Conventional pharmacological interventions often target single pathogenic pathways, leading to limited efficacy, high recurrence rates, and significant side effects due to the inherent complexity and multi-genic nature of MetS. This review comprehensively examines the rationale and methodology for designing polyherbal formulations, which leverage the principles of phytochemical synergy to provide a multi-target therapeutic approach. We define metabolic disorders, articulate the transition from mono-therapy to multi-component systems, detail the crucial design principles (including standardization, network pharmacology, and safety assessment), and review the mechanistic actions of key herbal constituents on critical metabolic pathways (e.g., AMPK activation, PPAR-gamma modulation, and inhibition of carbohydrate-digesting enzymes). The core proposition of this review is to properly designed, scientifically validated polyherbal formulations offer a superior, safer, and more holistic therapeutic alternative for managing the intricate pathophysiological cascades defining metabolic disorders. Finally, we discuss current regulatory hurdles and future directions for clinical integration and large-scale validation of these complex natural product systems.},
        keywords = {Metabolic Syndrome, Polyherbal Formulation, Synergy, Multi-target Therapy, Phytochemistry.},
        month = {January},
        }